GABA Signaling in Spatial Memory changes in Animal Model of Alzheimer’s disease by Bahareh Tavakoli-Far, Marjan Hosseini, Hadi Goudarzvand, Samira Choopani, Mahdi Goudarzvand

Subjects: Get full text

Novel targets for the treatment and prevention of Alzheimer's disease in the European population, inspiration from amyloid beta and tau protein by Xifeng Wang, Huayu Yang, Dengcheng Zhan, Haiying Sun, Qiang Huang, Yiping Zhang, Yue Lin, Gen Wei, Fuzhou Hua, Li Liu, Shibiao Chen

Subjects: Get full text

Prion meeting 2023: implications of a growing field by Tiago F. Outeiro, Tuane C. R. G. Vieira

Subjects: Get full text

Astrocytes phenomics as new druggable targets in healthy aging and Alzheimer’s disease progression by Daniele Lana, Filippo Ugolini, Ludovica Iovino, Selene Attorre, Maria Grazia Giovannini

Subjects: Get full text

Deciphering the Role of Adrenergic Receptors in Alzheimer’s Disease: Paving the Way for Innovative Therapies by Androulla N. Miliotou, Andria Kotsoni, Lefteris C. Zacharia

Subjects: Get full text

Neuroprotective effect of ranolazine in mice's model of Alzheimer's disease by Mariam H. Sadiq, Adeeb A. Al-Zubaidy, Nawres L. Wahhab

Subjects: Get full text

New Insights into the Development of Donepezil-Based Hybrid and Natural Molecules as Multi-Target Drug Agents for Alzheimer’s Disease Treatment by Violina T. Angelova, Boris P. Stoyanov, Rumyana Simeonova

Subjects: Get full text

Cerebrospinal Fluid Classical Biomarker Levels in Mixed vs. Pure A⁺T⁺ (A⁺T₁⁺) Alzheimer’s Disease by Ioanna Tsantzali, Athanasia Athanasaki, Fotini Boufidou, Vasilios C. Constantinides, Maria-Ioanna Stefanou, Christos Moschovos, Christina Zompola, Sotirios G. Paraskevas, Anastasios Bonakis, Sotirios Giannopoulos, Georgios Tsivgoulis, Elisabeth Kapaki, George P. Paraskevas

Subjects: Get full text

Hypertension moderates the relationship between plasma beta-amyloid and cognitive impairment: a cross-sectional study in Xi’an, China by Ziyu Liu, Yaoli He, Simeng Cui, Liangjun Dang, Binyan Zhang, Jin Wang, Wenhui Lu, Kang Huo, Yu Jiang, Chen Chen, Ling Gao, Shan Wei, Yi Zhao, Ningwei Hu, Jingyi Wang, Hong Lv, Hong Lv, Qiumin Qu, Qiumin Qu, Suhang Shang

Subjects: “…beta-amyloid…”
Get full text

OATP1A2 mediates Aβ1-42 transport and may be a novel target for the treatment of Alzheimer’s disease by Jinhua Wen, Menghua Zhao, Yuwei Xiao, Sihong Li, Weiqiang Hu

Subjects: Get full text

Understanding recent advances in non‐amyloid/non‐tau (NANT) biomarkers and therapeutic targets in Alzheimer's disease by Linda J. Van Eldik, Eric R. Siemers, Emily C. Collins, Michael Gold, David Henley, Peter Johannsen, Hans J. Möbius, Melanie Shulman, Jin Zhou, Maria Carrillo, Christopher Weber

Subjects: Get full text

Recent advances in potential enzymes and their therapeutic inhibitors for the treatment of Alzheimer's disease by Zahra Farajzadeh Vahid, Morteza Eskandani, Hamed Dadashi, Somayeh Vandghanooni, Mohammad-Reza Rashidi

Subjects: Get full text

Post-translational modifications of beta-amyloid modulate its effect on cell mechanical properties and influence cytoskeletal signaling cascades by Kseniya B. Varshavskaya, Evgeny P. Barykin, Roman V. Timoshenko, Vasilii S. Kolmogorov, Vasilii S. Kolmogorov, Alexander S. Erofeev, Petr V. Gorelkin, Vladimir A. Mitkevich, Alexander A. Makarov

Subjects: Get full text

Suppression of MT5-MMP Reveals Early Modulation of Alzheimer’s Pathogenic Events in Primary Neuronal Cultures of 5xFAD Mice by Dominika Pilat, Jean-Michel Paumier, Laurence Louis, Christine Manrique, Laura García-González, Delphine Stephan, Anne Bernard, Raphaëlle Pardossi-Piquard, Frédéric Checler, Michel Khrestchatisky, Eric Di Pasquale, Kévin Baranger, Santiago Rivera

Subjects: Get full text

Therapeutic agents for Alzheimer’s disease: a critical appraisal by Marta Weinstock

Subjects: “…antibodies against beta amyloid…”
Get full text